Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
Front Cell Infect Microbiol ; 11: 748739, 2021.
Article in English | MEDLINE | ID: mdl-34869059

ABSTRACT

Currently, the mortality rate in Saudi Arabia's ICUs is increasing due to the spread of Klebsiella pneumoniae carbapenemase (KPC)-producing bacteria. This study was carried out to evaluate the ability of biologically synthesized zinc oxide nanoparticles (ZnO-NPs) using Aspergillus niger to overcome carbapenem-resistant K. pneumoniae (KPC) in vitro and in vivo. ZnO-NPs were synthesized via a biological method and characterized using UV-Vis spectroscopy, Zetasizer and zeta potential analyses, x-ray diffraction spectroscopy, Fourier transform infrared spectroscopy, scanning electron microscopy (SEM), and energy-dispersive x-ray spectroscopy (EDX). In vitro sensitivity of KPC to ZnO-NPs was identified using the well diffusion method. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were determined by a macro-dilution method. The morphological alteration of KPC cells after ZnO-NPs treatment was observed by SEM. The in vivo susceptibility of KPC cells to ZnO-NPs ointment was evaluated using wound healing in experimental rats. The chemical characterization findings showed the formation, stability, shape, and size of the synthesized nanoparticles. The MIC and MBC were 0.7 and 1.8 mg/ml, respectively. The in vivo results displayed reduced inflammation and wound re-epithelialization of KPC-infected rats. These findings demonstrated that ZnO-NPs have great potential to be developed as antibacterial agents.


Subject(s)
Metal Nanoparticles , Nanoparticles , Pneumonia , Zinc Oxide , Animals , Anti-Bacterial Agents/pharmacology , Aspergillus niger , Carbapenems/pharmacology , Klebsiella pneumoniae , Microbial Sensitivity Tests , Plant Extracts , Rats , Spectroscopy, Fourier Transform Infrared , Zinc Oxide/pharmacology
3.
Molecules ; 26(7)2021 Mar 29.
Article in English | MEDLINE | ID: mdl-33805514

ABSTRACT

Recently, concerns have been raised globally about antimicrobial resistance, the prevalence of which has increased significantly. Carbapenem-resistant Klebsiella pneumoniae (KPC) is considered one of the most common resistant bacteria, which has spread to ICUs in Saudi Arabia. This study was established to investigate the antibacterial activity of biosynthesized zinc oxide nanoparticles (ZnO-NPs) against KPC in vitro and in vivo. In this study, we used the aqueous extract of Acacia nilotica (L.) fruits to mediate the synthesis of ZnO-NPs. The nanoparticles produced were characterized by UV-vis spectroscopy, zetasizer and zeta potential analyses, X-ray diffraction (XRD) spectroscopy, Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), energy-dispersive X-ray spectroscopy (EDX), and transmission electron microscopy (TEM). The antimicrobial activity of ZnO-NPs against KPC was determined via the well diffusion method, and determining minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC), the results showed low MIC and MBC when compared with the MIC and MBC of Imipenem and Meropenem antibiotics. The results of in vitro analysis were supported by the results upon applying ZnO-NP ointment to promote wound closure of rats, which showed better wound healing than the results with imipenem ointment. The biosynthesized ZnO-NPs showed good potential for use against bacteria due to their small size, applicability, and low toxicity to human cells.


Subject(s)
Anti-Infective Agents , Klebsiella Infections/drug therapy , Klebsiella pneumoniae/drug effects , Metal Nanoparticles , Plant Extracts/chemistry , Zinc Oxide , Acacia/chemistry , Animals , Anti-Infective Agents/pharmacology , Anti-Infective Agents/therapeutic use , Carbapenem-Resistant Enterobacteriaceae/drug effects , Green Chemistry Technology , Humans , Male , Metal Nanoparticles/chemistry , Metal Nanoparticles/therapeutic use , Rats , Rats, Sprague-Dawley , Zinc Oxide/pharmacology , Zinc Oxide/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...